Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPL38 pseudogene 2 is a processed *pseudogene* related to the functional ribosomal protein L38 gene (RPL38). Unlike the parent gene, which encodes a component of the 60S ribosomal subunit involved in protein synthesis, RPL38P2 does not encode a functional protein. Pseudogenes such as this may occasionally have biological roles by acting as non-coding RNAs (for example, regulating gene expression via miRNA "sponge" activity), but these functions are mostly speculative and not well characterized for RPL38P2 specifically. The parent gene RPL38 is associated with ribosome structure, protein synthesis, and certain developmental syndromes, but pseudogenes like RPL38P2 are generally not considered therapeutic targets and have no established disease associations, clinical relevance, or safety concerns[1][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L38 pseudogene 2 (RPL38P2).